ArticleProceedings (Baylor University. Medical Center)2025
Fragmented QRS complex as a predictor of no-reflow in myocardial infarction: a systematic review and meta-analysis.
Article in Proceedings (Baylor University. Medical Center), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Prediction of coronary no-reflow from the surface electrocardiogram.Proceedings (Baylor University. Medical Center) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary no-reflow is associated with adverse outcomes in patients with myocardial infarction (MI). This study aimed to evaluate the association between the presence of fragmented QRS (fQRS) and no-reflow in MI patients. Methods: A systematic search was conducted across four databases from inception to July 20, 2024. The inclusion criteria were studies that enrolled MI patients, stratified by the presence of fQRS, and reported at least one of the following outcomes: no-reflow, infarct size, reinfarction, or repeat revascularization during hospitalization. No-reflow was defined as a Thrombolysis In Myocardial Infarction (TIMI) flow grade < 3. Results: A total of 19 studies with 5840 participants were analyzed using a random-effects model. The presence of fQRS was associated with a higher risk of no-reflow compared to non-fQRS in MI patients, with an odds ratio (OR) of 2.08 (95% CI 1.39 to 3.12), Conclusions: The presence of fQRS was associated with a higher risk of no-reflow in MI patients. fQRS could serve as a useful tool for predicting no-reflow and guiding primary prevention strategies in MI patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.